| Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ... Pharmacoeconomics 34, 227-244, 2016 | 120 | 2016 |
| Die Berechnung von Kosten und Nutzen W Greiner Gesundheitsökonomische Evaluationen: Dritte, vollständig öberarbeitete …, 2007 | 92* | 2007 |
| Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries O Damm, B Ultsch, J Horn, RT Mikolajczyk, W Greiner, O Wichmann BMC Public Health 15, 1-19, 2015 | 54 | 2015 |
| The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study MA Rose, O Damm, W Greiner, M Knuf, P Wutzler, JG Liese, H Krüger, ... BMC infectious diseases 14, 1-13, 2014 | 53 | 2014 |
| Estimating the long-term effects of HPV vaccination in Germany J Horn, O Damm, MEE Kretzschmar, Y Deleré, O Wichmann, ... Vaccine 31 (19), 2372-2380, 2013 | 53 | 2013 |
| Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany O Damm, M Eichner, MA Rose, M Knuf, P Wutzler, JG Liese, H Krüger, ... The European Journal of Health Economics 16, 471-488, 2015 | 51 | 2015 |
| Methoden der gesundheitsökonomischen Evaluation in der Versorgungsforschung A Icks, N Chernyak, K Bestehorn, B Brüggenjürgen, J Bruns, O Damm, ... Das Gesundheitswesen 72 (12), 917-933, 2010 | 51 | 2010 |
| Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review O Damm, J Witte, S Wetzka, C Prosser, S Braun, R Welte, W Greiner International Journal of Public Health 61, 847-860, 2016 | 38 | 2016 |
| Current and future effects of varicella and herpes zoster vaccination in Germany–Insights from a mathematical model in a country with universal varicella vaccination J Horn, A Karch, O Damm, ME Kretzschmar, A Siedler, B Ultsch, ... Human vaccines & immunotherapeutics 12 (7), 1766-1776, 2016 | 34 | 2016 |
| Vaccination of children with a live-attenuated, intranasal influenza vaccine–analysis and evaluation through a Health Technology Assessment F Andersohn, R Bornemann, O Damm, M Frank, T Mittendorf, U Theidel GMS Health Technology Assessment 10, 2014 | 19 | 2014 |
| Gesundheitsökonomischer Kurz-HTA-Bericht „Rückenschmerzen “ O Damm, W Greiner Universität Bielefeld und Bertelsmann Stiftung, Bielefeld, 2007 | 18 | 2007 |
| Gesundheitsökonomischer Kurz-HTA-Bericht „Rückenschmerzen “ O Damm, W Greiner Universität Bielefeld und Bertelsmann Stiftung, Bielefeld, 2007 | 18 | 2007 |
| Assessment of public health and economic impact of intranasal live-attenuated influenza vaccination of children in France using a dynamic transmission model L Gerlier, M Lamotte, S Grenèche, X Lenne, F Carrat, C Weil-Olivier, ... Applied health economics and health policy 15, 261-276, 2017 | 17 | 2017 |
| A systematic review of herpes zoster vaccine acceptance O Damm, J Witte, W Greiner Value in Health 18 (7), A592, 2015 | 16 | 2015 |
| Gesundheitsbezogene Versorgungsforschung mit GKV-Routinedaten–Grenzen am Beispiel der Prophylaxe venöser Thromboembolien in der Hüft-und Kniegelenkendoprothetik D Bowles, O Damm, W Greiner Gesundheitsökonomie & Qualitätsmanagement 16 (02), 96-107, 2011 | 11 | 2011 |
| Methods of health economic evaluation for health services research A Icks, N Chernyak, K Bestehorn, B Brüggenjürgen, J Bruns, O Damm, ... Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2010 | 11 | 2010 |
| Estimates of the public health impact of a pediatric vaccination program using an intranasal tetravalent live-attenuated influenza vaccine in Belgium L Gerlier, M Lamotte, S Dos Santos Mendes, O Damm, M Schwehm, ... Pediatric Drugs 18, 303-318, 2016 | 10 | 2016 |
| Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors O Damm, M Nocon, S Roll, C Vauth, S Willich, W Greiner GMS health technology assessment 5, 2009 | 9 | 2009 |
| Methodological standards for cost-of-illness studies using breast cancer, prostate cancer and colon cancer as an example O Damm, JM Hodek, W Greiner Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 103 (6 …, 2009 | 9 | 2009 |
| Impfung gegen humane Papillomaviren (HPV) zur Prävention HPV 16/18 induzierter Zervixkarzinome und derer Vorstufen O Damm, M Nocon, S Roll, C Vauth, SN Willich, W Greiner GMS Health Technology Assessment 5 (2009) 5, Doc04, 2009 | 8 | 2009 |
